Werewolf Therapeutics, Inc. (HOWL) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$60.29M | -7.3% |
| 2024 | -$56.19M | -72.3% |
| 2023 | -$32.61M | +19.7% |
| 2022 | -$40.60M | +5.3% |
| 2021 | -$42.88M | -130.2% |
| 2020 | -$18.62M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$60.29M | -7.3% |
| 2024 | -$56.19M | -72.3% |
| 2023 | -$32.61M | +19.7% |
| 2022 | -$40.60M | +5.3% |
| 2021 | -$42.88M | -130.2% |
| 2020 | -$18.62M | — |